NYSE:JNJ
JNJ is in multi decade uptrend peaked at 187 – presumably end of major wave 5 and turned into Elliott ABC correction, where major wave (A) length is about 37. Per fibo relation major wave (C) should most probably end at 139.5, while intermediate wave ‘c’ – a unit of the major wave (C) might break the pattern bringing the end of correction to 133 and...
In April, we anticipated a pullback for JNJ, and since then, the stock has dropped approximately 7%, aligning with our expectations. The current trend suggests further downward movement, reinforcing our previous analysis.
We are focusing on the support zone ranging from $134 to $116, with a potential lower bound at $109, the Corona-Low. The ongoing pullback could...
Core Issues:
* J&J faces numerous lawsuits alleging its talc products contain asbestos and cause cancer.
* The company's utilization of a "Texas two-step" bankruptcy strategy to shield assets from litigation has drawn accusations of fraud.
Recent Developments:
* Cancer victims filed a class action lawsuit on May 22nd, 2024, alleging J&J's fraudulent use of...
If you haven`t bought JNJ before the previous earnings:
Then analyzing the options chain and the chart patterns of JNJ Johnson & Johnson prior to the earnings report this week,
I would consider purchasing the 145usd strike price Puts with
an expiration date of 2025-1-17,
for a premium of approximately $7.55.
If these options prove to be profitable prior to the...
Johnson & Johnson (NYSE: NYSE:JNJ ) has kicked off 2024 with a resounding victory, showcasing robust first-quarter earnings that outpaced Wall Street estimates and signaling a promising trajectory for the rest of the year.
The pharmaceutical giant reported an impressive adjusted EPS of $2.71, marking a remarkable 12.4% surge compared to the previous year. This...
Johnson & Johnson (JNJ) quickly hit the $147.00 Target that we set on our very recent sell call (April 03, see chart below) and is now approaching the bottom of the massive 2-year Channel Down:
Even though based on the very reliable and consistent Sine Waves, the bottom might be a process that can take up to 2-months, the stock is low enough for medium-term...
Johnson & Johnson gives a very clear idea of its trend on the 1M timeframe. The price may be under the 1D MA50 but has reached the bottom of the multi year Channel Up that started at the bottom of the 2008-2009 crisis. Being neutral on the 1M technical outlook (RSI = 45.714, MACD = -1.180, ADX = 20.525) has historically been one of the best buy opportunities, in...
Johnson & Johnson (JNJ) got rejected on its 1D MA200 (orange trend-line) - 1D MA50 (blue trend-line) Resistance Zone. It has been practically trading sideways since the start of the year and based on the Sine Waves, that priced the new Top (Lower Highs trend-line) of the 2-year Channel Down pattern.
The expected completion of a Bearish Cross this week on the 1W...
The last earnings report on September 30 showed earnings per share of $2.66, beating the estimate of $2.51. P/B Ratio (5.353) is normal, around the industry mean (5.180). P/E Ratio (29.715) is within average values for comparable stocks, (34.823). Projected Growth (PEG Ratio) (1.572) is also within normal values, averaging (3.115). Dividend Yield (0.030) settles...
SPDR Select Sector Fund – Healthcare Index AMEX:XLV
The chart speaks for itself, we have our breakout levels and our break down levels. We enter on a breakout and set a stop 5% under that support and we exit and or short if we fall under the two underside support levels.
Below I outline some reasons why the healthcare sector is worth paying attention too....
Hello TradingView Family / Fellow Traders. This is Richard, also known as theSignalyst.
📈 JNJ has exhibited an overall bullish trend, trading within the ascending wedge pattern outlined in blue. It is presently nearing the lower boundary/blue trendline.
At present, JNJ is undergoing a correction phase and is trading within the descending red channel. It is...
I was bullish on JNJ until I saw this today. We have broken through a long time support. With a strong Heikin Ashi candlestick. I am waiting to see if there is substantial volume at the close and then I would enter some maybe week out puts. The green line would be my profit target for JNJ. #jnj #puts
As you can see here on the daily time frame, we have respected this level on the weekly time frame support level. I am watching to buy at the close of a strong green heikin ashi candle stick bounce off of this zone with high volume. Keep your charts simple! As always, thank you for watching and reading my analysis.
JNJ touched Support (1) at 153.20, a level holding since June 1st.
Along with Support (2) at 150.10 are the major buy levels for the long term.
The medium term Resistance is the MA200 (1d).
Trading Plan:
1. Buy on the current market price.
2. If Support (1) breaks, buy on Support (2).
Targets:
1. 162.00 (expected contact point with the MA200 (1d)).
2. 161.00...
Hello TradingView Family / Fellow Traders. This is Richard, also known as theSignalyst.
Today we are going to go over a practical example on #JNJ , but you can apply the same logic / strategy on any instrument.
Feel free to ask questions or request any instrument for the next episode.
📚 Always remember to follow your trading plan when it comes to entry, risk...
Hello, according to Johnson & Johnson stock analysis. There is a good opportunity to buy or invest in stocks for the long term. Especially since the arrow came out of the rectangle. It also broke the resistance at 166. An ascending channel started to form, which indicates that the stock is very positive. Good luck everyone
It is plausible to consider that Johnson & Johnson's decision to spin off Kenvue might be linked to an effort to mitigate potential legal liabilities stemming from its talc-based products, which have been implicated in cases of cancer in the US and Canada. This strategic maneuver could potentially offer a layer of legal protection. Shareholders are expected to...
